Samsung BioLogics loses $6 billion in stocks dive after notice of accounting breach

SEOUL (Reuters) – Shares in Samsung BioLogics Co Ltd tumbled nearly 20 percent on Wednesday, losing almost $6 billion in value in their biggest daily intra-day fall, after South Korea’s financial watchdog provisionally decided it had breached an accounting rule.

Source: Reuters Medical News

Leave a Reply

Your email address will not be published. Required fields are marked *